v3.25.3
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 504,387 $ 2,401,359 $ 2,403,363 $ 6,011,201
Selling, general and administrative (including related party amounts of $334,050, $0, $334,050, and $0, respectively) 1,256,284 824,294 3,469,842 3,301,753
Total operating expenses 1,760,671 3,225,653 5,873,205 9,312,954
Loss from operations (1,760,671) (3,225,653) (5,873,205) (9,312,954)
Other income and expenses:        
Interest income 68,682 52,497 176,536 176,431
Net loss $ (1,691,989) $ (3,173,156) $ (5,696,669) $ (9,136,523)
Net loss per share of Common Stock, basic $ (1.65) $ (20.41) $ (6.64) $ (102.18)
Net loss per share of Common Stock, diluted $ (1.65) $ (20.41) $ (6.64) $ (102.18)
Weighted-average basic Common Stock 1,026,457 155,465 858,015 89,414
Weighted-average diluted Common Stock 1,026,457 155,465 858,015 89,414

Source